Endometrial adenocarcinoma in a young woman

Background: Endometrial carcinoma usually occurs in post-menopausal women, but in three to five percent of cases, it affects patients under 40 years of age, who wish to preserve their fertility. Patients with polycystic ovarian syndrome (PCOS) and the features of this syndrome (including obesity, hyperinsulinemia, and hyperandrogenism) are at great risk of developing endometrial carcinoma. Case report: The authors report a case of endometrial adenocarcinoma at Stage I in a 37-year-old obese woman with PCOS who underwent surgical staging. Discussion: In young women with obesity and PCOS, a periodic evaluation of the endometrium and implementation of risk-reducing measures for the development of endometrial cancer are needed.

Endometrial adenocarcinoma; Atypical endometrial hyperplasia; Obesity; Polycystic ovarian syndrome; Surgery; Conservative treatment.

[1] Moscarini M., Ricciardi E., Quarto A., Maniglio P., Caserta D.: “Vaginal treatment of endometrial cancer: role in the elderly”. World J. Surg. Oncol., 2011, 9, 74.

[2] Neubauer N.L., Lurain J.R.: “The role of lymphadenectomy in surgical staging of endometrial cancer”. Int. J. Surg. Oncol., 2011, 2011, 814649. Epub 2011 Jul 10.

[3] Karimi-Zarchi M., Mousavi A.S., Behtash N., Chiti Z., Bokaie M.: “Conservative management of young women with endometrial carcinoma or complex atypical hyperplasia: report of three cases and literature review”. Eur. J. Gynaecol. Oncol., 2011, 32, 695.

[4] Minig L., Franchi D., Boveri S., Casadio C., Bocciolone L., Sideri M.: “Progestin intrauterine device and GnRH analogue for uterussparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women”. Ann. Oncol., 2011, 22, 643.

[5] Balen A.: “Polycystic ovary syndrome and cancer.” Hum. Reprod. Update, 2001, 7, 522.

[6] Fader A.N., Arriba L.N., Frasure H.E., von Gruenigen V.E.: “Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship”. Gynecol. Oncol., 2009, 114, 121.

[7] Gadducci A., Gargini A., Palla E., Fanucchi A., Genazzani A.R. “Polycystic ovary syndrome and gynecological cancers: is there a link?”. Gynecol. Endocrinol., 2005, 20, 200.

[8] Wild S., Pierpoint T., Jacobs H., McKeigue P.: “Long-term consequences of polycystic ovary syndrome: results of a 31 year followup study”. Hum. Fertil. (Camb), 2000, 3, 101.

[9] Fauser B.C., Tarlatzis B.C., Rebar R.W., Legro R.S., Balen A.H., Lobo R. et al.: “Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRMSponsored 3rd PCOS Consensus Workshop Group”. Fertil. Steril., 2012, 97, 28.

[10] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: “Revised 2003 consensus on diagnostic criteria and long-term health risk related to polycystic ovary syndrome”. Fertil. Steril., 2004, 81, 19.

[11] Lo J.C., Feigenbaum S.L., Yang J., Pressman A.R., Selby J.V., Go A.S.: “Epidemiology and adverse cardiovascular risk profile of diagnosed polycystic ovary syndrome”. J. Clin. Endocrinol. Metab., 2006, 91, 1357.

[12] Wild R.A., Carmina E., Diamanti-Kandarakis E., Dokras A., Escobar-Morreale H.F., Futterweit W. et al.: “Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AEPCOS) Society”. J. Clin. Endocrinol. Metab., 2010, 95, 2038.

[13] Chittenden B.G., Fullerton G., Maheshwari A., Bhattacharya S.: “Polycystic ovary syndrome and the risk of gynaecological cancer: a systematic review”. Reprod Biomed Online. 2009, 19, 398.

[14] Haoula Z., Salman M., Atiomo W.: “Evaluating the association between endometrial cancer and polycystic ovary syndrome”. Hum. Reprod., 2012, 27, 1327.

[15] Navaratnarajah R., Pillay O.C., Hardiman P.: “Polycystic ovary syndrome and endometrial cancer”. Semin. Reprod. Med., 2008, 26, 62.

[16] Manchana T., Khemapech N.: “Endometrial adenocarcinoma in young Thai women”. Asian Pac. J. Cancer Prev., 2008, 9, 283.